BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
Vote for Target Test Prep, Newsweek Readers’ Choice Awards 2026
NEWSWEEK READERS’ CHOICE 2026

BIG NEWS! Target Test Prep has been nominated, and they’d love your vote!

TTP has worked incredibly hard to build the best test prep experience possible, and winning Newsweek’s 2026 Readers’ Choice Award for Best Test Prep would mean a lot to them. If TTP has helped you, they’d be incredibly grateful for your vote. You can vote once each day through September 9.

Vote for TTP
GMATLiveTeach 7 seats left
Chris Peckover
NEXT LIVE COHORT

Oct 13 to Jan 7, 2027

with Chris Peckover

Schedule
Tue, Thu · 8:00 to 10:00 PM ET
Included
40 live hours + 6 months of GMAT OnDemand
  • Live instruction and real-time questions
  • Class recordings and assigned practice
View class & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions
Start free 5-day trial
Read 559 reviewsTarget Test Prep

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

Investment funds and pharmaceutical corporations

Expert replies
Post new topic Post Reply
Previous Topic Next Topic
Master | Next Rank: 500 Posts
Posts: 132
Joined: Thu Dec 02, 2010 2:49 am
Thanked: 5 times
by RadiumBall » Wed Mar 30, 2011 9:02 pm
Research and development partnerships between investment funds and pharmaceutical corporations are experiencing considerable growth worldwide, even though products developed jointly by two or more corporations are less profitable than products developed by a single corporation. The advantage of research and development partnerships is that such arrangements may allow pharmaceutical firms to create successful products that would otherwise be too costly to develop.

Which of the following is information provided by the passage above?


(A) Product development is too costly for a single corporation to fund without research and development partnerships.
(B) Product development partnerships between pharmaceutical corporations and investment funds are more common now than they were in the recent past.
(C) Product development partnerships lead to products of higher quality.
(D) Joint research ventures between pharmaceutical corporations and investment funds produce exclusively costly products.
(E) Joint research ventures between pharmaceutical corporations and investment funds primarily benefit the investment funds.
Top
Join the discussion
Log in to postLogin with Googleuse password
QUOTE IN REPLY
Source: — Critical Reasoning |
User avatar
Community Manager
Posts: 991
Joined: Thu Sep 23, 2010 6:19 amFollowed by: 24 members
Location: Bangalore, India
Thanked: 146 times

by shovan85 » Wed Mar 30, 2011 10:10 pm
RadiumBall wrote:Research and development partnerships between investment funds and pharmaceutical corporations are experiencing considerable growth worldwide, even though products developed jointly by two or more corporations are less profitable than products developed by a single corporation. The advantage of research and development partnerships is that such arrangements may allow pharmaceutical firms to create successful products that would otherwise be too costly to develop.

Which of the following is information provided by the passage above?

(A) Product development is too costly for a single corporation to fund without research and development partnerships.
(B) Product development partnerships between pharmaceutical corporations and investment funds are more common now than they were in the recent past.
(C) Product development partnerships lead to products of higher quality.
(D) Joint research ventures between pharmaceutical corporations and investment funds produce exclusively costly products.
(E) Joint research ventures between pharmaceutical corporations and investment funds primarily benefit the investment funds.

I can discard B, D, and E (as highlighted in red).
Between A and C, C has a term "Quality", which I cannot say how the author is trying to define it. If the term "Higher Quality" means Successful or More costly.
So, IMO A
If the problem is Easy Respect it, if the problem is tough Attack it
Top
Join the discussion
Log in to postLogin with Googleuse password
QUOTE IN REPLY
Master | Next Rank: 500 Posts
Posts: 132
Joined: Thu Dec 02, 2010 2:49 am
Thanked: 5 times

by RadiumBall » Wed Mar 30, 2011 10:21 pm
Actually even I selected A but the OA: B. I am not sure how.

I don't know how well is the question formed though. Because I found another CR ill-prepared https://www.beatthegmat.com/spear-grass-t76073.html
Top
Join the discussion
Log in to postLogin with Googleuse password
QUOTE IN REPLY
Legendary Member
Posts: 586
Joined: Tue Jan 19, 2010 4:38 amFollowed by: 5 members
Thanked: 31 times
GMAT Score:730

by rohu27 » Thu Mar 31, 2011 3:12 am
Source and any OE?
Top
Join the discussion
Log in to postLogin with Googleuse password
QUOTE IN REPLY
Legendary Member
Posts: 857
Joined: Wed Aug 25, 2010 1:36 amFollowed by: 15 members
Thanked: 56 times

by AIM GMAT » Thu Mar 31, 2011 3:42 am
PREMISE : Research and development partnerships between investment funds and pharmaceutical corporations are experiencing considerable growth worldwide, even though products developed jointly by two or more corporations are less profitable than products developed by a single corporation.

PREMISE : The advantage of research and development partnerships is that such arrangements may allow pharmaceutical firms to create successful products that would otherwise be too costly to develop.



(A) Product development is too costly for a single corporation to fund without research and development partnerships. - Stated with possibility this optiondepicts surety .

(B) Product development partnerships between pharmaceutical corporations and investment funds are more common now than they were in the recent past. - Premise bold part infers the trend as recent development

I was very tempted picking A , but gave a second thought and caught glimpse of word "may". Is this knewton problem ? If yes then i liked their style of framing questions that compell to read minutely and pick the words those go unnoticed .

Dnt be a charity while reading the GMAT way
-- Nice article by David Newland (Guys go thru it ... :) )
Thanks & Regards,
AIM GMAT
Top
Join the discussion
Log in to postLogin with Googleuse password
QUOTE IN REPLY
Legendary Member
Posts: 586
Joined: Tue Jan 19, 2010 4:38 amFollowed by: 5 members
Thanked: 31 times
GMAT Score:730

by rohu27 » Thu Mar 31, 2011 4:00 am
AIM,
I completely agree wth choice A. It states blatantly tht it IS too costly.
but wth option B i interpreted the premise as follows:
"Research and development partnerships between investment funds and pharmaceutical corporations are experiencing considerable growth worldwide" - this only says that they are experiencing considerable growth now - it only talks about the growth, may be they were in existence from long but the growth has been a recnet phenomenon.

but option B clearly says " Product development partnerships between pharmaceutical corporations and investment funds are more common now than they were in the recent past" - that they are common now.

or do we need to look at it this way: as the growth is considerable in recent times, they have become more common? coz the premise no where states their EXISTENCE is more common now,(that is what option B mentions)

Help me out in my thought process!!
Top
Join the discussion
Log in to postLogin with Googleuse password
QUOTE IN REPLY
Legendary Member
Posts: 857
Joined: Wed Aug 25, 2010 1:36 amFollowed by: 15 members
Thanked: 56 times

by AIM GMAT » Thu Mar 31, 2011 4:09 am
Patnership is experiencing growth => more patnerships

And the 2nd premise states that

The advantage of research and development partnerships is that such arrangements may allow pharmaceutical firms to create successful products that would otherwise be too costly to develop.

=> apart from not so costly products patnership may allow to develop costly product also .
Thanks & Regards,
AIM GMAT
Top
Join the discussion
Log in to postLogin with Googleuse password
QUOTE IN REPLY
Master | Next Rank: 500 Posts
Posts: 132
Joined: Thu Dec 02, 2010 2:49 am
Thanked: 5 times

by RadiumBall » Thu Mar 31, 2011 4:28 am
Yes this from Knewton. I am not happy with B and still consider that the question is wrongly framed, because B talks of only a part of the given premise. A on the other hand seems to cover more of the information given in the premise.
Top
Join the discussion
Log in to postLogin with Googleuse password
QUOTE IN REPLY
Legendary Member
Posts: 586
Joined: Tue Jan 19, 2010 4:38 amFollowed by: 5 members
Thanked: 31 times
GMAT Score:730

by rohu27 » Thu Mar 31, 2011 4:32 am
AIM GMAT wrote:Patnership is experiencing growth => more patnerships

this is point we need to arrive at. else i feel this Q is best solved by POE. come dwn to A and B, A tweaks MAY into IS, so fo gor B.
Top
Join the discussion
Log in to postLogin with Googleuse password
QUOTE IN REPLY
Post new topic Post Reply
• Page 1 of 1